NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCT1032180086

Registered date:17/01/2019

PRT for skull base chordoma and chondrosarcoma.

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedSkull base chordoma or chondrosarcoma
Date of first enrollment22/03/2019
Target sample size60
Countries of recruitment
Study typeInterventional
Intervention(s)Proton Radiation Therapy

Outcome(s)

Primary Outcome3 year local recurrence free survival
Secondary Outcome5 or 10 year local recurrence free survival, Late toxicity

Key inclusion & exclusion criteria

Age minimum>= 15age old
Age maximumNot applicable
GenderBoth
Include criteria1, Pathological diagnosis is chordoma or chondrosarcoma 2, General condition is maintained (PS 0-2 or PS 3 caused by tumor) 3, When tumor is controlled,5-year survival is expected. 4, Obtain written informed consent. 5, 15 years old or more.
Exclude criteria1, Multiple primary cancers 2, Invasion for brain stem or optic chiasm 3, Distant metastases 4, Active infectious meningitis 5, Pregnant, unwilling to practice contraception during study, or lactating female. 6, Not suitable for participation by mental illnesses 7, Difficult to participate by the judgment of a doctor

Related Information

Contact

Public contact
Name Masashi Mizumoto
Address Amakubo 2-1-1, Tsukuba, Ibaraki Ibaraki Japan 3058576
Telephone +81-29-853-7100
E-mail mizumoto@pmrc.tsukuba.ac.jp
Affiliation University of Tsukuba Hospital
Scientific contact
Name Hideyuki Sakurai
Address Amakubo 2-1-1, Tsukuba, Ibaraki Ibaraki Japan 305-8576
Telephone +81-298537100
E-mail hsakurai@pmrc.tsukuba.ac.jp
Affiliation University of Tsukuba Hospital